The -94 Ins polymorphism in the NFKB1 promoter was inversely associated with the clinical stage and tumor size in female patients, which suggests that certain factors in relationship with gender disparity may influence the malignant pathological features of HCC by manipulating the NF-κB-mediated signal pathway. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.